- Visibility 14 Views
- Downloads 10 Downloads
- Permissions
- DOI 10.18231/j.ijpo.12006.1759139906
-
CrossMark
Borderline phyllodes tumor – A saga of recurrences and malignant transformation
- Author Details:
-
Neelam Sood *
-
Ruhi .
Neelam Sood *
Ruhi .
Background: Phyllodes tumors (PTs) of the breast are rare fibroepithelial neoplasms with variable biological behaviour. While most cases are benign, some recur with increasing aggressiveness and histologic transformation. This study evaluates a case series of borderline phyllodes tumors from last 10 years records and their morphological evolution.
Materials and Methods: A retrospective cohort study was conducted on recurrent phyllodes tumors, which were initially diagnosed as either benign or borderline. The records of last 10 years were retrieved. Out of total number of 30 diagnosed phyllodes tumors, 5 were recurrent. Their slides were reviewed and morphological parameters were evaluated. The clinical demographic parameters, clinical parameters including interval between the first diagnosis and recurrence and surgical margins were also evaluated.
Results: Among these five cases, three showed transformation to sarcoma, over a period of 1-5years, one of them in first recurrence itself,another in second recurrence and third in third recurrence. One case has heterologous elements in form of well differentiated liposarcoma. With each recurrence, there was a progressive reduction in the epithelial component. One case remained borderline phyllodes even after three recurrences, and one of them transformed from benign to borderline Phyllodes tumors. In four out of five cases the stromal hypercellularity was seen in the first presentation. Extent of surgical margins had no bearing on recurrence; however infiltrative margins were seen in two cases, on initial presentation.
Conclusion: Phyllodes tumors may evolve into more aggressive histologic subtypes upon recurrence, often with diminishing epithelial elements. Early recognition of these changes is essential for prognosis and management planning with close follow ups.
References
- Borella F, Porpiglia M, Gallio N, Cito C, Boriglione L, Capella G, et al. Borderline Phyllodes Breast Tumors: A Comprehensive Review of Recurrence, Histopathological Characteristics, and Treatment Modalities. Curr Oncol. 2025;32(2):66. https://doi.org/10.3390/curroncol32020066
[Google Scholar] - Zhang Y, Kleer CG. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates. Arch Pathol Lab Med . 2016;140(7):665–71. https://doi.org/10.5858/arpa.2016-0042-RA
[Google Scholar] - Simpson A, Li P, Dietz J. Diagnosis and management of phyllodes tumors of the breast. Ann Breast Surg. 2021;5. https://doi.org/10.21037/abs-20-99
[Google Scholar] - Gunasekaran G, Naik D, Sharma S, Bhandari V, Mandal AK, Rajput D. Recurrent phyllodes tumor of the breast transforming to a fibrosarcoma. Int Surg J. 2016;1(3):173–6. Available from: https://www.ijsurgery.com/index.php/isj/article/view/466.
- Mayorga-Pérez I, Mulero-Soto P, Cruz-De La Rosa K, Negrón- González V, Hernandez-Rosa J, Feneque-Gonzalez J, et al. Bilateral phyllodes tumor: Case report. J Pediatr Surg Case Rep. 2024;101:102753. https://doi.org/10.1016/j.epsc.2023.102753
[Google Scholar] - Samii E, Hurni Y, Huber D. Management and Outcomes of Metastatic and Recurrent Malignant Phyllodes Tumors of the Breast: A Systematic Literature Review. Eur J Breast Health. 2023;19(3):191–200.
- Atram M, Gupta A, Gangane NM. Malignant Phyllodes Tumor with Heterologous Sarcomatous Differentiation: a Case Series and Review of Literature. Indian J Surg Oncol. 2022;13(4):723–30. https://doi.org/10.1007/s13193-022-01525-7
[Google Scholar] - Cook W, Lee CS, Tan PH. Epithelial Carcinomas Arising within Phyllodes Tumours of the Breast: A Review of Their Pathological Characteristics. Pathobiology. 2024;91(2):144–57. https://doi.org/10.1159/000533745
[Google Scholar] - Tummidi S, Kothari K, Agnihotri M, Naik L, Sood P. Fibroadenoma versus phyllodes tumor: a vexing problem revisited! BMC Cancer. 2020;20(1):648. https://doi.org/10.1186/s12885-020-07129-0
[Google Scholar] - WHO Classification of Tumours Editorial Board. Breast Tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2019. (WHO Classification of Tumours).
- Seal SKF, Kuusk U, Lennox PA. Bilateral and multifocal phyllodes tumours of the breast: A case report. Can J Plast Surg. 2010;18(4):145–6.
- Athamnah MN, Abuelaish OM, Rabai NA. Multifocal intra- parenchymal and sub-pectoral malignant phyllodes tumor in young female, rare and unusual presentation: A case report. Int J Surg Case Rep. 2020;71:280–4. https://doi.org/10.1016/j.ijscr.2020.05.014
[Google Scholar] - Li X, Nguyen TTA, Zhang J, et al. Validation Study of the Newly Proposed Refined Diagnostic Criteria for Malignant Phyllodes Tumor With 136 Borderline and Malignant Phyllodes Tumor Cases. Am J Surg Pathol. 2024;48(9):1146–53. https://doi.org/10.1097/PAS.0000000000002264
[Google Scholar] - Niyonkuru E, Nisabwe S, Sami Z, Faizi I, Mazti A, Elkarroumi M, et al. Cystic squamous metaplasia in a giant benign phyllodes tumor of the breast: a case report. J Surg Case Rep. 2023;2023(7):rjad402. https://doi.org/10.1093/jscr/rjad402
[Google Scholar] - Ali MNA, Nasaruddin AF, Mohamed SS, Rahman WF. Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast. Asian Pac J Cancer Prev. 2020;21(9):2653–9. https://doi.org/10.31557/APJCP.2020.21.9.2653
[Google Scholar] - Rakha EA, Brogi E, Castellano I, Quinn C. Spindle cell lesions of the breast: a diagnostic approach. Virchows Arch. 2022;480(1):127–
- https://doi.org/10.1007/s00428-021-03162-x
[Google Scholar] - Jabeen D, Vohra LM, Siddiqui T, Raza A. Recurrent Phyllodes Tumour of the Breast Transforming to a Fibrosarcoma. Cureus. 2020;12(3):e7457. https://doi.org/10.7759/cureus.7457
[Google Scholar] - Narla SL, Stephen P, Kurian A, Annapurneswari S. Well- differentiated liposarcoma of the breast arising in a background of malignant phyllodes tumor in a pregnant woman: A rare case report and review of literature. Indian J Pathol Microbiol. 2018;61(4):577–9. https://doi.org/10.4103/IJPM.IJPM_238_17
[Google Scholar] - Donato AR, Goncalves R, Maesaka JY, Aguiar FN, Soares JM Jr, Ruiz CA, et al. Phyllodes tumors of the breast: A comprehensive review of diagnosis, treatment, and follow-up. Clinics (Sao Paulo). 2025;80:100617. https://doi.org/10.1016/j.clinsp.2025.100617
[Google Scholar] - Dixit N, Suri M, Trivedi S, Shams A. Primary breast stromal sarcoma: A rare case report. Indian J Pathol Oncol. 2020;7(3):486–
- https://doi.org/10.18231/j.ijpo.2020.096
[Google Scholar] - Ma Q, Liu YB, She T, Liu XL. The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients. Breast Cancer (Dove Med Press). 2024;16:117–26. https://doi.org/10.2147/BCTT.S451617
[Google Scholar] - Soliman NA, Yussif SM. Ki-67 as a prognostic marker according to breast cancer molecular subtype. Cancer Biol Med. 2016;13(4):496–504. https://doi.org/10.20892/j.issn.2095-3941.2016.0066
[Google Scholar] - Lei T, Song Y, Shen Z, Shi Y, Xia C, Deng X, et al. Malignant phyllodes tumors with sarcomatous components: A histopathologic and molecular study. Transl Oncol. 2025;53:102318. https://doi.org/10.1016/j.tranon.2025.102318
[Google Scholar] - Tsang JY, Shao Y, Poon IK, Ni YB, Kwan JS, Chow C, et al. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology. 2022;54(6):678–85. https://doi.org/10.1016/j.pathol.2022.03.008
[Google Scholar] 266 Sood and Ruhi / Indian Journal of Pathology and Oncology 2025;12(3):258–266 - Kim JY, Yu JH, Nam SJ, Kim SW, Lee SK, Park WY, et al. Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast. Transl Oncol. 2018;11(1):18–23. https://doi.org/10.1016/j.tranon.2017.10.002
[Google Scholar]